ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $10,000 | +66.7% | 105 | 0.0% | 0.00% | +100.0% |
Q3 2021 | $6,000 | -14.3% | 105 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $7,000 | 0.0% | 105 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $7,000 | -12.5% | 105 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $8,000 | 0.0% | 105 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $8,000 | +14.3% | 105 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $7,000 | +75.0% | 105 | 0.0% | 0.00% | +50.0% |
Q1 2020 | $4,000 | -20.0% | 105 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $5,000 | 0.0% | 105 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $5,000 | -16.7% | 105 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $6,000 | +20.0% | 105 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $5,000 | +25.0% | 105 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $4,000 | -60.0% | 105 | -51.6% | 0.00% | -66.7% |
Q3 2018 | $10,000 | -9.1% | 217 | -11.4% | 0.00% | -50.0% |
Q2 2018 | $11,000 | -8.3% | 245 | -19.7% | 0.01% | -14.3% |
Q1 2018 | $12,000 | -14.3% | 305 | -24.7% | 0.01% | -12.5% |
Q4 2017 | $14,000 | +75.0% | 405 | +26.6% | 0.01% | +60.0% |
Q3 2017 | $8,000 | +60.0% | 320 | 0.0% | 0.01% | +66.7% |
Q2 2017 | $5,000 | – | 320 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |